Original Research
Accepted on 29 Jul 2025
Retrospective analysis of the efficacy and safety of anlotinib plus sintilimab (anti-PD-1) as maintenance therapy in advanced pediatric solid tumors
in Pediatric Oncology
Original Research
Accepted on 29 Jul 2025
in Pediatric Oncology
Case Report
Accepted on 29 Jul 2025
in Gynecological Oncology
Retraction
Accepted on 29 Jul 2025
in Organizational Psychology
Case Report
Accepted on 29 Jul 2025
in Nuclear Medicine
Review
Accepted on 29 Jul 2025
in Breast Cancer
Retraction
Accepted on 29 Jul 2025
in Organizational Psychology
Retraction
Accepted on 29 Jul 2025
in Environmental Psychology
Editorial
Accepted on 29 Jul 2025
in Theoretical and Philosophical Psychology
Original Research
Accepted on 29 Jul 2025
in Hematology
Original Research
Accepted on 29 Jul 2025
in Food Characterization
Editorial
Accepted on 29 Jul 2025
in Movement Disorders
Original Research
Accepted on 29 Jul 2025
in Plant Pathogen Interactions
Retraction
Accepted on 29 Jul 2025
in Organizational Psychology
Review
Accepted on 29 Jul 2025
in Neuropharmacology
Brief Research Report
Accepted on 29 Jul 2025
in Pediatric Oncology
Technology and Code
Accepted on 29 Jul 2025
in Drugs Outcomes Research and Policies